Heron Therapeutics, Inc. /De/ (HRTX) Insider Ownership

Historic Insider Ownership Trends

Heron Therapeutics's top three insider shareholders as of April 22, 2026 are Capital Management Lp Rubric (TenPercentOwner, 30.05Mn shares), Capital Management Lp Rubric (TenPercentOwner, 30.05Mn shares), Adam Morgan (Director, 8.75Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Capital Management Lp Rubric - 0 30,046,828 17 Oct, 2025
Capital Management Lp Rubric - 0 30,046,828 17 Oct, 2025
Adam Morgan - 0 8,753,290 12 Aug, 2025
Adam Morgan - 0 8,753,290 12 Aug, 2025
Adam Morgan - 0 6,986,744 25 Jul, 2023
Adam Morgan - 0 6,986,744 25 Jul, 2023
Craig A Collard Chief Executive Officer 648,255 0 06 Apr, 2026
Ira Duarte Evp, Chief Financial Officer 195,356 0 03 Feb, 2026
William P Forbes Evp, Chief Development Officer 181,773 0 03 Feb, 2026
Adam Morgan - 123,737 0 03 Feb, 2026
Adam Morgan - 123,737 0 03 Feb, 2026
Susan Rodriguez - 87,180 0 04 Feb, 2025
Lisa Peraza Vp, Chief Accounting Officer 55,907 0 16 Jan, 2024
Lisa Peraza Vp, Chief Accounting Officer 55,907 0 16 Jan, 2024
Craig A Johnson - 53,960 0 03 Feb, 2026
Craig A Johnson - 53,960 0 03 Feb, 2026
Sharmila Dissanaike - 53,960 0 03 Feb, 2026
Thomas Cusack - 53,960 0 03 Feb, 2026
Waage Christian - 53,960 0 03 Feb, 2026
Stephen Davis - 52,032 0 20 Dec, 2022
John Poyhonen President Cco 46,648 0 17 Apr, 2023
David Leslie Szekeres Evp, Chief Operating Officer 33,754 0 17 Jul, 2023
David Leslie Szekeres Evp, Chief Operating Officer 33,754 0 17 Jul, 2023
Kimberly Manhard Evp, Drug Development 28,330 0 17 Apr, 2023
Kimberly Manhard Evp, Drug Development 28,330 0 17 Apr, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
03 Apr, 2026 Craig A Collard Common Stock A 62,500 - 648,255 D M
03 Apr, 2026 Craig A Collard Restricted Stock Units D 62,500 $0.00 62,500 D M
30 Jan, 2026 William P Forbes Restricted Stock Units A 188,315 $0.00 188,315 D A
30 Jan, 2026 Craig A Collard Restricted Stock Units A 800,337 $0.00 800,337 D A
31 Jan, 2026 William P Forbes Common Stock A 11,695 - 181,773 D M
30 Jan, 2026 Waage Christian Common Stock A 53,960 $0.00 53,960 D A
31 Jan, 2026 Ira Duarte Common Stock A 11,695 - 195,356 D M
30 Jan, 2026 Thomas Cusack Common Stock A 53,960 $0.00 53,960 D A
30 Jan, 2026 Mark Earl Hensley Restricted Stock Units A 188,315 $0.00 188,315 D A
30 Jan, 2026 Ira Duarte Restricted Stock Units A 216,562 $0.00 216,562 D A
30 Jan, 2026 Adam Morgan Common Stock A 53,960 $0.00 123,737 D A
31 Jan, 2026 Craig A Collard Common Stock A 34,789 - 571,710 D M
30 Jan, 2026 Sharmila Dissanaike Common Stock A 53,960 $0.00 53,960 D A
30 Jan, 2026 Craig A Johnson Common Stock A 53,960 $0.00 53,960 D A
30 Jan, 2026 Craig A Collard Performance Stock Units A 800,336 $0.00 800,336 D A
31 Jan, 2026 William P Forbes Restricted Stock Units D 11,695 $0.00 140,332 D M
31 Jan, 2026 Craig A Collard Restricted Stock Units D 34,789 $0.00 417,464 D M
30 Jan, 2026 Ira Duarte Performance Stock Units A 216,561 $0.00 216,561 D A
30 Jan, 2026 William P Forbes Performance Stock Units A 188,314 $0.00 188,314 D A
30 Jan, 2026 Mark Earl Hensley Performance Stock Units A 188,314 $0.00 188,314 D A